Page last updated: 2024-09-05

1,3-dipropylxanthine and furosemide

1,3-dipropylxanthine has been researched along with furosemide in 1 studies

Compound Research Comparison

Studies
(1,3-dipropylxanthine)
Trials
(1,3-dipropylxanthine)
Recent Studies (post-2010)
(1,3-dipropylxanthine)
Studies
(furosemide)
Trials
(furosemide)
Recent Studies (post-2010) (furosemide)
260013,6311,3582,486

Protein Interaction Comparison

ProteinTaxonomy1,3-dipropylxanthine (IC50)furosemide (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)3.76
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)3.76
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)3.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, A; Karasawa, A; Kubo, K; Mizumoto, H; Nonaka, H; Ohno, T; Shimada, J; Suzuki, F1

Other Studies

1 other study(ies) available for 1,3-dipropylxanthine and furosemide

ArticleYear
8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Animals; Diuretics; Indicators and Reagents; Kidney; Kidney Function Tests; Kinetics; Male; Molecular Structure; Rats; Rats, Inbred Strains; Receptors, Purinergic; Structure-Activity Relationship; Xanthines

1991